Skip to main content

Inhibitor IκBα promoter functional polymorphisms in patients with multiple sclerosis

Abstract

The aim of this study is to investigate the association of IκBα promoter polymorphisms with the development of Multiple Sclerosis (MS) disease in Iranian population. One hundred and fifty patients with MS along with 150 unrelated healthy controls were enrolled in this study. The IκBα −881A/G (rs3138053), −826C/T (rs2233406) and −519C/T (rs2233408) polymorphisms were determined by the polymerase chain reaction/restriction fragment length polymorphism method. This study demonstrated that the genotype frequencies of IκBα −881A/G and −826T/T, and allele frequencies of IκBα−881G were significantly higher in patients with MS with respect to as compared to the controls. We also found that the estimated haplotype frequency of IκBα promoter −881G–826T–519C was significantly increased in the patient with MS in comparison with that of the healthy individuals. This study reveals that polymorphisms in the IκBα promoter (−881 A/G, −826 C/T) are strongly associated with the susceptibility of Iranian MS patients.

This is a preview of subscription content, access via your institution.

References

  1. Noteworthy J, Lucchinetti C, Rodriguez M, Weinshenker B (2000) Medical progress: multiple sclerosis. New Engl J Med 343:938–952

    Article  Google Scholar 

  2. Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis results of an international survey. Neurology 46:907–911

    CAS  Article  PubMed  Google Scholar 

  3. Ramagopalan SV, Dobson R, Meier UC, Giovannoni G (2010) Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol 9:727

    Article  PubMed  Google Scholar 

  4. Dyment DA, Ebers GC, Dessa Sadovnick A (2004) Genetics of multiple sclerosis. Lancet Neurol 3:104–110

    CAS  Article  PubMed  Google Scholar 

  5. Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C, Hunt SE (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476:214–219

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  6. Sospedra M, Martin R (2005) Immunology of multiple sclerosis. Annu Rev Immunol 23:683–747

    CAS  Article  PubMed  Google Scholar 

  7. Liang Y, Zhou Y, Shen P (2004) NF-kappaB and its regulation on the immune system. Cell Mol Immunol 1:343–350

    CAS  PubMed  Google Scholar 

  8. Gveric D, Kaltschmidt C, Cuzner ML, Newcombe J (1998) Transcription factor NF-kappaB and inhibitor I kappaBalpha are localized in macrophages in active multiple sclerosis lesions. J Neuropath Exp Neurol 57:168

    CAS  Article  PubMed  Google Scholar 

  9. Chen F, Castranova V, Shi X, Demers LM (1999) New insights into the role of nuclear factor-κB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem 45:7–17

    CAS  PubMed  Google Scholar 

  10. Qiutang L, Inder M (2002) NF-KB regulation in the immune system. Immunology 2:725–734

    Google Scholar 

  11. Mozzato-Chamay N, Corbett E, Bailey R, Mabey D, Raynes J, Conway D (2001) Polymorphisms in the IkappaB-alpha promoter region and risk of diseases involving inflammation and fibrosis. Genes Immun 2:153

    CAS  Article  PubMed  Google Scholar 

  12. Ito CY, Kazantsev AG, Baldwin AS Jr (1994) Three NF-χB sites in the IχB-α promoter are required for induction of gene expression by TNFα. Nucleic Acids Res 22:3787–3792

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  13. Lin C-H, Wang S-C, Ou T-T, Li R-N, Tsai W-C, Liu H-W, Yen J-H (2008) IκBα promoter polymorphisms in patients with systemic lupus erythematosus. J Clin Immunol 28:207–213

    CAS  Article  PubMed  Google Scholar 

  14. Lin CH, Ou TT, Wu CC, Tsai WC, Liu HW, Yen JH (2007) IκBα promoter polymorphisms in patients with rheumatoid arthritis. Int J Immunogenet 34:51–54

    CAS  Article  PubMed  Google Scholar 

  15. Ou T-T, Lin C-H, Lin Y-C, Li R-N, Tsai W-C, Liu H-W, Yen J-H (2008) IkBα promoter polymorphisms in patients with primary Sjögren’s syndrome. J Clin Immunol 28:440–444

    CAS  Article  PubMed  Google Scholar 

  16. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227–231

    CAS  Article  PubMed  Google Scholar 

  17. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127

    CAS  Article  PubMed  Google Scholar 

  18. Todaro M, Zerilli M, Triolo G, Iovino F, Patti M, Accardo-Palumbo A, Gaudio F, Turco MC, Petrella A, Maria R (2005) NF-κB protects Behçet’s disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins. Arthritis Rheum 52:2179–2191

    CAS  Article  PubMed  Google Scholar 

  19. Iwai K, Lee BR, Hashiguchi M, Fukushima A, Iwashima M (2005) IkB-α-specific transcript regulation by the C-terminal end of c-Rel. FEBS Lett 579:141–144

    CAS  Article  PubMed  Google Scholar 

  20. Siebenlist U, Franzoso G, Brown K (1994) Structure, regulation and function of NF-kappaB. Annu Rev Cell Biol 10:405–455

    CAS  Article  PubMed  Google Scholar 

  21. Arenzana-Seisdedos F, Turpin P, Rodriguez M, Thomas D, Hay RT, Virelizier J-L, Dargemont C (1997) Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm. J Cell Sci 110:369–378

    CAS  PubMed  Google Scholar 

  22. Miterski B, Böhringer S, Klein W, Sindern E, Haupts M, Schimrigk S, Epplen J (2002) Inhibitors in the NFκB cascade comprise prime candidate genes predisposing to multiple sclerosis, especially in selected combinations. Genes Immun 3:211–219

    CAS  Article  PubMed  Google Scholar 

  23. Li R-N, Hung Y-H, Lin C-H, Chen Y-H, Yen J-H (2010) Inhibitor IκBα promoter functional polymorphisms in patients with rheumatoid arthritis. J Clin Immunol 30:676–680

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by Tarbiat Modares University and we thank Dr. Manshadi and Dr. Taghikhani for providing normal samples.

Conflict of interest

No potential conflicts of interest were disclosed.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Seyed Alireza Mesbah-Namin.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Balood, M., Mesbah-Namin, S.A., Sanati, M.H. et al. Inhibitor IκBα promoter functional polymorphisms in patients with multiple sclerosis. Mol Biol Rep 41, 613–616 (2014). https://doi.org/10.1007/s11033-013-2898-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-013-2898-3

Keywords

  • IkBα
  • Multiple sclerosis
  • Polymorphism